Arrowhead Pharmaceuticals Inc
ARWR
$58.37+0.41%
End of day · as of Oct 15, 2026, 4:15 AM ET
Mkt cap
$10.59B
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$829.45M
EPS (TTM)
$-2.28
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-0.20%
Beta
1.29
Div yield
N/A
Sector
Healthcare
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was -$1.6M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Use this ARWR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ARWR income, balance, and cash tables.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company in the Healthcare sector.
Latest cached Arrowhead Pharmaceuticals Inc (ARWR) revenue for Sep 30, 2025 was $829.4M. Net income was -$1.6M. Statements: https://lician.com/financials/arwr
Arrowhead Pharmaceuticals Inc (ARWR) market capitalization is $10.59B on the latest cached snapshot.
Arrowhead Pharmaceuticals Inc (ARWR) cached previous close $58.13; day range $58.37 – $58.94; volume 4,158,702. Session quote: https://lician.com/quote/arwr
Arrowhead Pharmaceuticals Inc (ARWR) latest cached earnings event is "ARWR earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ARWR filing is 8-K · Jan 12, 2026. Filings: https://lician.com/sec/arwr